Maravai LifeSciences Holdings, Inc. - Class A common stock (NQ:MRVI)

3.640 +0.090 (+2.54%)

Streaming Delayed Price Updated: 12:12 PM EDT, Apr 27, 2026 Add to My Watchlist

Price and Volume

Volume	467,274
Open	3.540
Bid (Size)	3.630 (10,500)
Ask (Size)	3.640 (5,800)
Prev. Close	3.550
Today's Range	3.500 - 3.640
52wk Range	1.950 - 4.105
Shares Outstanding	112,280,375
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Maravai Lifesciences (NASDAQ:MRVI) Returns to Positive Adjusted EBITDA and Issues 2026 Guidance ↗

February 25, 2026

Via Chartmill

Top movers in Wednesday's after hours session ↗

February 25, 2026

Via Chartmill

Performance

YTD	+7.1%	+7.1%
1 Month	+27.3%	+27.3%
3 Month	-1.6%	-1.6%
6 Month	+9.0%	+9.0%
1 Year	+81.1%	+81.1%

More News

Maravai Lifesciences Reports Fourth Quarter and Full Year 2025 Financial Results

February 25, 2026

From Maravai LifeSciences Holdings, Inc.

Via Business Wire

Maravai LifeSciences To Host Earnings Conference Call on Wednesday, February 25, 2026

February 09, 2026

From Maravai LifeSciences, Inc.

Via Business Wire

Earnings Scheduled For November 6, 2025 ↗

November 06, 2025

Via Benzinga

What to Expect from Maravai LifeSciences's Earnings ↗

August 08, 2025

Via Benzinga

Teleflex Stock Slides 39% in a Year, but This $8.5 Million Buy Signals a Contrarian Bet ↗

February 06, 2026

Via The Motley Fool

What to Know About a New $9 Million Bet on an Energy Distributor Stock ↗

February 06, 2026

Via The Motley Fool

This Biopharma Stock Has Surged Nearly 100% and One Fund Just Locked in Gains With a $10 Million Exit ↗

February 06, 2026

Via The Motley Fool

Maravai LifeSciences Announces November 2025 Investor Conference Schedule

November 10, 2025

From Maravai LifeSciences, Inc.

Via Business Wire

Maravai LifeSciences (MRVI) Stock Plummets After Q3 2025 Revenue Miss and Weak Guidance ↗

November 06, 2025

Via Chartmill

Maravai LifeSciences Reports Third Quarter 2025 Financial Results

November 06, 2025

From Maravai LifeSciences Holdings, Inc.

Via Business Wire

MARAVAI INVESTIGATION REMINDER: Bragar Eagel & Squire, P.C. Continues Investigation on Behalf of Maravai Long-Term Stockholders

October 29, 2025

From Bragar Eagel & Squire

Via GlobeNewswire

Maravai LifeSciences To Host Earnings Conference Call on Thursday, November 6, 2025

October 22, 2025

From Maravai LifeSciences, Inc.

Via Business Wire

MARAVAI (MRVI) INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. Reminds Investors of the Investigation into Maravai LifeSciences Holdings, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

October 02, 2025

From Bragar Eagel & Squire

Via GlobeNewswire

MARAVAI INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. Continues Investigation into Maravai LifeSciences Holdings, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

September 09, 2025

From Bragar Eagel & Squire

Via GlobeNewswire

Maravai LifeSciences Reports Second Quarter 2025 Financial Results

August 11, 2025

From Maravai LifeSciences Holdings LLC

Via GlobeNewswire

Beyond the Headlines: A Look at Today's Key Corporate Earnings Reports

August 11, 2025

Via MarketMinute

Maravai LifeSciences To Host Earnings Conference Call on Monday, August 11, 2025

July 28, 2025

From Maravai LifeSciences Holdings LLC

Via GlobeNewswire

Earnings Scheduled For August 11, 2025 ↗

August 11, 2025

Via Benzinga

MARAVAI LIFESCIENCES INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Maravai LifeSciences Holdings, Inc. - MRVI

July 25, 2025

From Kahn Swick & Foti, LLC

Via Business Wire

July 22, 2025

From Bragar Eagel & Squire

Via GlobeNewswire

MARAVAI ALERT: Bragar Eagel & Squire, P.C. is Investigating Maravai LifeSciences Holdings, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

July 14, 2025

From Bragar Eagel & Squire

Via GlobeNewswire

MARAVAI ALERT: Bragar Eagel & Squire, P.C. is Investigating Maravai LifeSciences Holdings, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

July 08, 2025

From Bragar Eagel & Squire

Via GlobeNewswire

MARAVAI LIFESCIENCES INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Maravai LifeSciences Holdings, Inc. - MRVI

June 27, 2025

From Kahn Swick & Foti, LLC

Via Business Wire

Frequently Asked Questions

Is Maravai LifeSciences Holdings, Inc. - Class A common stock publicly traded?

Yes, Maravai LifeSciences Holdings, Inc. - Class A common stock is publicly traded.

What exchange does Maravai LifeSciences Holdings, Inc. - Class A common stock trade on?

Maravai LifeSciences Holdings, Inc. - Class A common stock trades on the Nasdaq Stock Market

What is the ticker symbol for Maravai LifeSciences Holdings, Inc. - Class A common stock?

The ticker symbol for Maravai LifeSciences Holdings, Inc. - Class A common stock is MRVI on the Nasdaq Stock Market

What is the current price of Maravai LifeSciences Holdings, Inc. - Class A common stock?

The current price of Maravai LifeSciences Holdings, Inc. - Class A common stock is 3.640

When was Maravai LifeSciences Holdings, Inc. - Class A common stock last traded?

The last trade of Maravai LifeSciences Holdings, Inc. - Class A common stock was at 04/27/26 12:12 PM ET

What is the market capitalization of Maravai LifeSciences Holdings, Inc. - Class A common stock?

The market capitalization of Maravai LifeSciences Holdings, Inc. - Class A common stock is 408.70M

How many shares of Maravai LifeSciences Holdings, Inc. - Class A common stock are outstanding?

Maravai LifeSciences Holdings, Inc. - Class A common stock has 409M shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.